Legend Biotech USA Inc. CARVYKTI ® (ciltacabtagene autoleucel; cilta-cel) net trade sales of approximately $369 million Over 6,000 patients treated to date Initiated CARVYKTI ® clinical ...

(RTTNews) - Purple Biotech Ltd. (PPBT, PPBT.TA), an Israeli clinical-stage biotechnology company, on Monday announced that it has appointed Shai Lankry as its Chief Financial Officer. Lankry has ...

Portage Biotech's PORT-7 showed >90% tumor growth inhibition with anti-PD1 combo in a murine mesothelioma model. PORT-7 single-agent activity outperformed anti-PD1 treatment alone; first-in-human ...

A biotech company says it has bred three animals with key physical features of the dire wolf — a species that has been extinct for more than 12,000 years. Colossal Biosciences says it used novel ...

Congress should invest at least $15 billion to support biotech research over the next five years and take other steps to bolster manufacturing in the U.S., while barring companies from working ...

AmplifyBio, once one of central Ohio's most promising biotech firms, announced Friday that it has shut down. In a posting on its website, the company said the decision followed months of efforts ...

The layoffs are scheduled for May 28. — Nkarta, a biotech company, 53 job cuts in South San Francisco. The downsizing occurred on March 31. The job cuts were all described as permanent ...

(Note: Jyong Biotech Ltd. increased its IPO’s size to 2.67 million shares – up from 2.33 million shares – and kept the price range at $7.50 to $8.50 – to raise $21.36 million, according to ...

Ltd. iOx specializes in developing liposomal iNKT agonists, with its lead candidate, PORT-2, showing encouraging early clinical results. PRTG Price Action: Portage Biotech stock is up 102.93% at $ ...

BEIJING - Sinovac Biotech Ltd. (NASDAQ:SVA), a prominent biopharmaceutical company in China with a current market capitalization of $35.58 million, has announced the appointment of Sven H.

There remains much uncertainty about these measures, however. As ever in the often quick-developing biotech and pharmaceutical sectors on Tuesday, companies posted a mix of positive and negative news.